HALEEZY TABLET

Indications

• Uncomplicated malaria caused by Plasmodium falciparum
• Other forms of malaria as indicated by susceptibility testing
• Potential use in combination therapy for multidrug-resistant malaria

Dosage

Children: Refer to the BNF for Children for age and weight-specific dosing information.

Adults: Refer to established guidelines and pharmacological resources for specific dosing recommendations based on the type and severity of malaria.

Mechanism of action

Antamul acts by inhibiting the growth of Plasmodium species through interference with their ability to metabolize hemoglobin and utilize heme. The drug accumulates in the parasite's food vacuole, leading to toxic levels of heme, which ultimately results in parasite death.

Pharmacodynamics

The pharmacodynamic profile of Antamul includes its ability to disrupt the life cycle of malaria parasites, leading to a reduction in parasitic load and alleviation of symptoms associated with malaria. It exhibits a rapid onset of action, effectively reducing fever and other malaria symptoms.

Pharmacokinetics

Antamul is well-absorbed when administered orally, with peak plasma concentrations occurring within a few hours. It undergoes hepatic metabolism, and its metabolites are primarily excreted via the kidneys. The half-life of Antamul varies but is typically in the range of several hours, necessitating multiple doses over the course of treatment to maintain therapeutic levels.

Pregnancy

Consult healthcare provider before use, as safety during pregnancy is not established.

Breast-feeding

Consult healthcare provider before use, as safety during breastfeeding is not established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Allergic rhinitis
• Urticaria
• Insomnia
• Motion sickness
• Anxiety disorders

Dosage

Children: Refer to specific dosing guidelines in professional references for paediatric doses, as they are determined by age, weight, and clinical condition.

Adults: Refer to specific dosing guidelines in professional references, as doses may vary based on indication and individual patient factors.

Mechanism of action

Ardusi exerts its effects by competitively inhibiting the H1 receptor, which prevents the action of endogenous histamine. This action leads to a decrease in the symptoms of allergy, such as itching, sneezing, and rhinorrhea. Additionally, it has anticholinergic properties that contribute to its sedative effects.

Pharmacodynamics

The drug displays dose-dependent sedative effects, which are beneficial in treating insomnia or anxiety-related conditions. Its anticholinergic effects can also contribute to dry mouth, blurred vision, and urinary retention. The onset of action typically occurs within 15-30 minutes, with a duration of effect that can last several hours, depending on the dose administered.

Pharmacokinetics

After oral administration, Ardusi is well absorbed from the gastrointestinal tract. It undergoes extensive first-pass metabolism in the liver, leading to a bioavailability that may vary between individuals. The drug is metabolized primarily by cytochrome P450 enzymes and is eliminated from the body mainly through urine, both as unchanged drug and metabolites. The half-life of diphenhydramine is approximately 4-8 hours, but this can be prolonged in elderly patients or those with hepatic impairment.

Pregnancy

The safety of Ardusi during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether Ardusi is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Anti-inflammatory conditions
• Osteoarthritis
• Rheumatoid arthritis
• Digestive disorders
• Skin conditions
• Metabolic syndrome

Dosage

Adults: There is no standard dosage for haldi as it depends on the form used (powder, capsules, etc.) and the intended purpose. General guidance suggests 400-600 mg of curcumin

Mechanism of action

Curcumin, the active ingredient in haldi, exerts its effects through multiple mechanisms, including the modulation of various signaling pathways. It inhibits nuclear factor kappa B (NF-κB), a transcription factor that plays a crucial role in inflammatory responses. Curcumin also affects the activity of various enzymes and receptors, including cyclooxygenase-2 (COX-2) and lipoxygenase, which are involved in inflammation. Additionally, curcumin has been shown to influence the expression of various genes related to inflammation and oxidative stress.

Pharmacodynamics

Haldi has demonstrated a range of pharmacological effects, primarily attributed to its anti-inflammatory and antioxidant properties. It can help reduce inflammation by inhibiting pro-inflammatory cytokines and enzymes. Curcumin's antioxidant activity helps neutralize free radicals, reducing oxidative stress and preventing cellular damage. Furthermore, it may have a potential role in modulating metabolic processes, enhancing insulin sensitivity, and supporting cardiovascular health.

Pharmacokinetics

Curcumin has low bioavailability due to its poor absorption in the gastrointestinal tract, rapid metabolism, and systemic elimination. It is primarily metabolized in the liver and intestines, resulting in the formation of various metabolites. The peak plasma concentration of curcumin occurs approximately 1-2 hours after oral administration, but due to its rapid clearance, its effects may be short-lived. Co-administration with substances like black pepper (which contains piperine) has been shown to enhance curcumin absorption significantly.

Contra-indications

• Hypersensitivity to curcumin or any of the excipients
• Biliary obstruction
• Gallbladder disorders

Adverse effects

• Gastrointestinal upset
• Nausea
• Diarrhea
• Allergic skin reactions
• Increased risk of bleeding

Interactions

• Anticoagulants and antiplatelet drugs (may increase bleeding risk)
• Drugs that lower blood sugar (may enhance hypoglycemic effect)
• Proton pump inhibitors (may alter absorption)

Precautions

• Use with caution in patients with gallstones or bile duct obstruction
• Monitor for signs of bleeding in patients on anticoagulant therapy
• Use cautiously in pregnant women and those with liver disease

Pregnancy

Limited data on safety, use only if potential benefits justify the risks.

Breast-feeding

Considered safe in small amounts, but high doses should be avoided.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered form
• Capsules
• Liquid extracts
• Tea

Indications

• Cough
• Bronchial asthma
• Respiratory infections
• Chronic obstructive pulmonary disease (COPD)

Dosage

Children: Dosage should be determined by a healthcare professional based on the child's age, weight, and clinical condition. Refer to established pediatric guidelines for specific dosing recommendations.

Adults: Dosage should be determined by a healthcare professional based on the condition being treated and individual patient factors. Refer to established guidelines for specific dosing recommendations.

Mechanism of action

The exact mechanism of action of kantkari is not fully elucidated. However, it is believed to exert its effects through the modulation of neurotransmitter systems and cytokine production, leading to bronchodilation and anti-inflammatory effects. The active constituents may enhance mucociliary clearance and reduce airway hyperreactivity.

Pharmacodynamics

Kantkari exhibits bronchodilator effects, which can help alleviate symptoms associated with respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, it may possess anti-inflammatory properties, reducing airway inflammation and mucus production. The plant's constituents may also exhibit antimicrobial activity, contributing to its use in treating respiratory infections.

Pharmacokinetics

The pharmacokinetic profile of kantkari has not been extensively studied. However, it is assumed that the active compounds are absorbed in the gastrointestinal tract and distributed throughout the body. The metabolism and excretion pathways remain unclear, necessitating further research to fully understand these aspects.

Pregnancy

There is insufficient reliable information regarding the safety of kantkari during pregnancy. It is advisable to avoid use unless absolutely necessary.

Breast-feeding

The excretion of kantkari in breast milk is not well studied. Caution is recommended when using this herb while breastfeeding.

Storage

Kantkari should be stored in a cool, dry place, away from direct sunlight and moisture.

Indications

• Respiratory disorders
• Inflammatory conditions
• Pain management
• Antioxidant support

Dosage

Children: Dosing information for children is not available. It is advisable to consult with a healthcare professional for guidance specific to pediatrics.

Adults: Dosing for Shirish has not been established in clinical guidelines. It is recommended to refer to traditional usage or consult with a healthcare professional for appropriate dosing.

Mechanism of action

The exact mechanism of action of Shirish (Albizia lebbeck) is not fully understood. However, it is believed to exhibit anti-inflammatory and analgesic effects, potentially through the inhibition of pro-inflammatory cytokines and pathways involved in pain perception. Some studies suggest it may have antioxidant properties, which contribute to its protective effects against oxidative stress.

Pharmacodynamics

Shirish has been noted for its potential effects on various biological systems. The active compounds found in the bark and leaves, such as flavonoids and saponins, may modulate inflammatory responses and provide analgesic effects. These compounds can influence nitric oxide production and the release of inflammatory mediators, thus impacting pain and inflammation pathways.

Pharmacokinetics

Limited pharmacokinetic data is available for Shirish. However, it is generally understood that the bioavailability and metabolism of plant-derived compounds can be influenced by factors such as extraction methods, preparation forms, and individual patient characteristics. The absorption, distribution, metabolism, and excretion of its active components may vary widely depending on these factors.

Pregnancy

Insufficient data available to assess safety during pregnancy. Consult healthcare provider.

Breast-feeding

Safety during breastfeeding is not established. Consult healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Acute muscle spasms
• Musculoskeletal pain
• Strains and sprains
• Back pain

Dosage

Children: Refer to established guidelines or clinical references for specific dosing recommendations for children, as paediatric dosages should be carefully determined based on age and weight.

Adults: Refer to established guidelines or clinical references for specific dosing recommendations, as doses can vary based on the clinical context and patient needs.

Mechanism of action

Somlata acts centrally in the brain, specifically within the spinal cord, to produce muscle relaxation. It is believed to inhibit polysynaptic reflexes, thereby reducing muscle tone and spasms. This central action differentiates it from direct-acting muscle relaxants which act directly on skeletal muscle.

Pharmacodynamics

The pharmacodynamic effects of somlata include a decrease in the frequency and intensity of muscle spasms, leading to improved mobility and comfort in patients suffering from acute musculoskeletal pain. Its sedative properties may also contribute to its muscle-relaxing effects, providing additional relief from associated discomfort.

Pharmacokinetics

Somlata is rapidly absorbed after oral administration, with peak plasma concentrations typically occurring within 1-2 hours. It undergoes extensive hepatic metabolism, with metabolites excreted primarily via the urine. The half-life of somlata can vary, but it is generally in the range of 2-3 hours. Due to its central action, caution is advised when co-administering with other central nervous system depressants.

Pregnancy

There is limited information on the safety of somlata during pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is unknown whether somlata is excreted in human milk. Caution should be exercised when administering somlata to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Stress relief
• Respiratory conditions
• Immune system support
• Anti-inflammatory conditions
• Antioxidant support
• Anxiety and depression

Dosage

Children: Refer to established guidelines or consult a healthcare professional, as specific dosing can vary based on the preparation and individual needs.

Adults: Refer to established guidelines or consult a healthcare professional, as specific dosing can vary based on the preparation and individual needs.

Mechanism of action

Tulsi contains various bioactive compounds, including eugenol, rosmarinic acid, and other flavonoids. These compounds exhibit anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines and modulating the activity of nuclear factor-kappa B (NF-kB), a key regulator of inflammatory responses. Additionally, Tulsi's antioxidant properties help in scavenging free radicals, thereby reducing oxidative stress in the body.

Pharmacodynamics

The pharmacodynamic profile of Tulsi is primarily attributed to its phytochemical constituents, which interact with various biological pathways. The herb is noted for its ability to enhance the activity of immune cells, improve stress resilience through modulation of cortisol levels, and potentially exert cardioprotective effects. Tulsi's adaptogenic effect is significant in promoting mental clarity and reducing anxiety.

Pharmacokinetics

While specific pharmacokinetic data for Tulsi is limited, studies suggest that its active constituents are well absorbed in the gastrointestinal tract. The metabolism of these compounds often involves hepatic enzymes, with a significant portion being excreted in urine. The half-life of Tulsi's components can vary, but the herb's effects may persist due to its cumulative action over time.

Adverse effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Hypoglycemia
• Hypotension

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• May enhance the effects of antidiabetic medications, leading to hypoglycemia
• May affect the metabolism of certain drugs metabolized by the liver

Precautions

• Use with caution in patients with diabetes due to its potential hypoglycemic effects
• Should be avoided in individuals with bleeding disorders or those on anticoagulant therapy
• Consult healthcare professionals before use in pregnancy or breastfeeding

Pregnancy

Tulsi is generally considered safe in moderation, but high doses should be avoided due to potential effects on hormone levels.

Breast-feeding

Tulsi is likely safe during breastfeeding, but it is recommended to consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried leaves
• Essential oil
• Extracts
• Teas